Banque Pictet & Cie’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-20,000
| Closed | -$464K | – | 305 |
|
|
2024
Q3 | $464K | Hold |
20,000
| – | – | ﹤0.01% | 252 |
|
|
2024
Q2 | $487K | Hold |
20,000
| – | – | ﹤0.01% | 250 |
|
|
2024
Q1 | $675K | Hold |
20,000
| – | – | 0.01% | 248 |
|
|
2023
Q4 | $631K | Hold |
20,000
| – | – | 0.01% | 247 |
|
|
2023
Q3 | $511K | Hold |
20,000
| – | – | 0.01% | 336 |
|
|
2023
Q2 | $574K | Hold |
20,000
| – | – | 0.01% | 373 |
|
|
2023
Q1 | $479K | Hold |
20,000
| – | – | ﹤0.01% | 468 |
|
|
2022
Q4 | $339K | Hold |
20,000
| – | – | ﹤0.01% | 551 |
|
|
2022
Q3 | $296K | Hold |
20,000
| – | – | ﹤0.01% | 568 |
|
|
2022
Q2 | $315 | Hold |
20,000
| – | – | ﹤0.01% | 572 |
|
|
2022
Q1 | $539K | Hold |
20,000
| – | – | ﹤0.01% | 524 |
|
|
2021
Q4 | $740K | Hold |
20,000
| – | – | 0.01% | 490 |
|
|
2021
Q3 | $956K | Hold |
20,000
| – | – | 0.01% | 261 |
|
|
2021
Q2 | $677K | Hold |
20,000
| – | – | 0.01% | 283 |
|
|
2021
Q1 | $826K | Hold |
20,000
| – | – | 0.01% | 266 |
|
|
2020
Q4 | $868K | Buy |
+20,000
| New | +$868K | 0.01% | 240 |
|